AB

Anurag Bhandari

Active Director Director DIN 07859154
DIN 07859154 First appointment Aug 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value •••• Premium profile

About Anurag Bhandari

Data last updated:

Anurag Bhandari is a Director at Affirma Health Private Limited (since 2022). The company operates in Pharma. Affirma Health Private Limited reported revenue of ₹59,460 (FY 2024).

DIN 07859154
Primary Designation Director
Industry Pharma
First Appointment 04 Aug 2022
Oldest Company Age 4 yrs
Largest company Affirma Health Private Limited · ₹59,460 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Affirma Health Private Limited U51909RJ2022PTC083016
Director04 Aug 20222022₹59,460 (FY 2024)Active

Board colleagues of Anurag Bhandari

NameDINCompanyDesignation
Chetan Goyal09696228Affirma Health Private LimitedDirector

Directorship timeline

Open interactive timeline →
Affirma Health Private Limited
Premium access

Shareholding and investment profile for Anurag Bhandari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anurag Bhandari

Anurag Bhandari currently holds 1 directorship: Affirma Health Private Limited (Director, since 04 Aug 2022, revenue ₹59,460 (FY 2024)).

Anurag Bhandari was first appointed on 04 Aug 2022 as Director at Affirma Health Private Limited.

The current boards of Anurag Bhandari's companies include Chetan Goyal (Affirma Health Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available